Completed NA INTERVENTIONAL 2-arm NCT02637453

Addition of Six Short Lines on Pulmonary Vein Isolation

Addition of Six Short Ablation Lines on Pulmonary Vein Isolation Circumferences Reduces Recurrence Rate of Paroxysmal Atrial Fibrillation

Sponsor: Shanghai Chest Hospital

Conditions Paroxysmal Atrial Fibrillation

Interventions CPVI+6L PVI

Updated 9 times since 2017 Last updated: Jun 10, 2021 Started: Jan 4, 2017 Primary completion: Jan 10, 2021 Completion: Jan 10, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Paroxysmal Atrial Fibrillation and is currently completed. Shanghai Chest Hospital leads this study, which shows 9 recorded versions since 2017 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Sep 2021 — Jul 2024 [monthly]

Completed NA
May 2021 — Sep 2021 [monthly]

Completed NA

Status: Unknown Status → Completed · Phase: PHASE4 → NA
Jan 2021 — May 2021 [monthly]

Unknown Status PHASE4

▶ Show 4 earlier versions

Jun 2019 — Jan 2021 [monthly]

Unknown Status PHASE4

Status: Recruiting → Unknown Status
Jun 2018 — Jun 2019 [monthly]

Recruiting PHASE4
Feb 2017 — Jun 2018 [monthly]

Recruiting PHASE4
Jan 2017 — Feb 2017 [monthly]

Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shanghai Chest Hospital
Shanghai East Hospital
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Xuzhou Central Hospital

Data source: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shanghai, China